Show simple item record

AdvisorAl-Badriyeh, Daoud
AuthorSHAFEI, LAILA KHALED
Available date2024-07-01T06:38:16Z
Publication Date2024-06
URIhttp://hdl.handle.net/10576/56300
AbstractObjective: To summarize the literature evidence towards the efficacy and safety of diabetic neuropathy (DNP) treatments, and to assess the cost-effectiveness among the DNP treatment regimens in Qatar, including the use of combination therapy. Methods: In Phase I, a systematic review of the literature meta-analyses and clinical trials, published until February 2024, was performed. In Phase II, a decision-analytic model, followed up by a 20-year horizon Markov model, was constructed to assess the relative short-term and long-term economic outcomes of DNP treatments from the public Qatari hospital perspective. Results: Duloxetine (DLX) approach, amitriptyline (AMT) approach, and pregabalin (PGB) approach were successful, by achieving 50% pain relief, in 50%, 40%, and 38% of patients, respectively. Over the short term, the 'DLX followed by DLX plus PGB' was the dominant regimen. For the long term, the 'PGB followed by PGB plus AMT' regimen was most cost-effective followed by 'AMT followed by AMT plus PGB'. Oneway and multivariate sensitivity analyses confirmed the robustness of results. Conclusion: The 'DLX followed by DLX plus PGB' regimen was dominant in the short term, while 'PGB followed by PGB plus AMT' was cost-effective on long-term.
Languageen
SubjectECONOMIC EVALUATION
DIABETIC NEUROPATHY MONOTHERAPY
COMBINATION THERAPY TREATMENT
TitleECONOMIC EVALUATION OF DIABETIC NEUROPATHY MONOTHERAPY FOLLOWED BY COMBINATION THERAPY TREATMENT
TypeMaster Thesis
DepartmentPharmacy
dc.accessType Full Text


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record